Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 19/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 19/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 18/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 18/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 16/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 13/20 | 0.43 |
| ▸ | HDAC5 | Q9UQL6 | 12/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 11/20 | 0.43 |
| ▸ | HDAC10 | Q969S8 | 11/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 11/20 | 0.43 |
| ▸ | HDAC9 | Q9UKV0 | 11/20 | 0.43 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | MMP13 | P45452 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2707021 | 1.00 | HDAC3 (0.43) | HDAC3HDAC1HDAC8HDAC6HDAC4 | |
| SCHEMBL9895121 | 0.90 | HDAC3 (0.46) | HDAC3HDAC1HDAC8HDAC6HDAC4 | |
| SCHEMBL181515 | 0.90 | HDAC3 (0.46) | HDAC3HDAC1HDAC8HDAC6HDAC4 | |
| SCHEMBL7899095 | 0.90 | HDAC3 (0.46) | HDAC3HDAC1HDAC8HDAC6HDAC4 | |
| SCHEMBL181516 | 0.90 | HDAC3 (0.46) | HDAC3HDAC1HDAC8HDAC6HDAC4 | |
| SCHEMBL2706460 | 0.85 | HDAC3 (0.53) | HDAC3HDAC1HDAC8HDAC6HDAC4 | |
| SCHEMBL2706465 | 0.85 | HDAC3 (0.53) | HDAC3HDAC1HDAC8HDAC6HDAC4 | |
| SCHEMBL2704501 | 0.84 | HDAC1 (0.37) | HDAC3HDAC1HDAC8HDAC6HDAC4 | |
| SCHEMBL2704508 | 0.84 | HDAC1 (0.37) | HDAC3HDAC1HDAC8HDAC6HDAC4 | |
| Trifluoroacetic Acid SCHEMBL9895341 | 0.84 | HDAC3 (0.41) | HDAC3HDAC1HDAC8HDAC6HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012025701-A1 | ALPHA, ALPHA - DI SUBSTITUTED GLYCINE ESTER DERIVATIVES AND THEIR USE AS HDAC INHIBITORS | CHROMA THERAPEUTICS LTD. (GB) | 2012-03-01 | — | — | WO | disclosed |